male reproductive organ cancer: A reproductive organ cancer that is manifested in the male genital system. This includes organs such as the penis and scrotum.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleonly males |
207946 |
2. Check conditionsNone |
207946 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
137 |
4. Check minimum number of eventsNone |
137 |
5. Include endpointsNone |
137 |
6. Filter based on genotype QC (FinnGen only) |
131 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Similar endpoints
↥List of similar endpoints to Benign neoplasm: Scrotum based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Scrotum
- Benign neoplasm of male genital organs
- Benign neoplasm of male genital organs
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 1111 | - | 1111 |
Only index persons | 936 | - | 936 |
Unadjusted period prevalence (%) | |||
Whole population | 0.03 | - | 0.03 |
Only index persons | 0.04 | - | 0.04 |
Median age at first event (years) | |||
Whole population | - | - | 43.64 |
Only index persons | - | - | 40.66 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 131 | - | 131 |
Unadjusted period prevalence (%) | 0.07 | - | 0.07 |
Median age at first event (years) | 47.54 | - | 47.54 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_SCROTUM and mortality.
Females
No dataMales
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_SCROTUM | 1.306 [0.98, 1.74] | 0.067 |
Birth year | 0.985 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 84 out of 605 males with CD2_BENIGN_SCROTUM died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_SCROTUM.N-year risk | Females | Males |
---|---|---|
1 | No data | 0.253% |
5 | No data | 1.561% |
10 | No data | 3.61% |
15 | No data | 6.871% |
20 | No data | 11.442% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SCROTUM – Benign neoplasm: Scrotum
GWS hits: -